During the past decade, Trakya Universitesi Tip Fakultesi conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 4 clinical trials were completed, i.e. on average, 36.4% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Trakya Universitesi Tip Fakultesi" #1 sponsor was "Bayer" with 4 trials, followed by "Incyte Corporation" with 3 trials sponsored, "Merck Sharp & Dohme LLC" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Trakya Universitesi Tip Fakultesi" #1 collaborator was "Merck Sharp & Dohme LLC" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 1 trials as a collaborator, "Ono Pharmaceutical Co. Ltd" with 1 trials as a collaborator, "Pierre Fabre Medicament" with 1 trials as a collaborator and "Zai Lab (Shanghai) Co., Ltd." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Trakya Universitesi Tip Fakultesi" are "BRAF V600E-mutant Metastatic Colorectal Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Gastric Neoplasms" (1 trials), "Gastroesophageal Junction Adenocarcinoma" (1 trials) and "Head and Neck Cancer" (1 trials). Many other conditions were trialed in "Trakya Universitesi Tip Fakultesi" in a lesser frequency.

Most popular intervention types in "Trakya Universitesi Tip Fakultesi" are "Drug" (11 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Cisplatin" (4 trials), "Pembrolizumab" (4 trials), "5-Fluorouracil" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Trakya Universitesi Tip Fakultesi" are 10 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Trakya Universitesi Tip Fakultesi". undefined are not yet recruiting, 3 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Trakya Universitesi Tip Fakultesi, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Trakya Universitesi Tip Fakultesi, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".